Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen Certified for Agilent Assays

NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has certified Asuragen to offer its array-based comparative genomic hybridization and microRNA assays along with its lab services offerings.

Agilent named Asuragen a certified service provider for these assays after a training and assessment program that included proficiency in analyzing Agilent's 60-mer oligo microarrays, providing sample quality control on the Agilent 2100 Bioanalyzer, using its reagents and protocols, scanner and extraction software, and using the GeneSpring bioinformatics platform for data analysis.

"Agilent's miRNA microarrays and Array CGH for DNA allow us to add another dimension to our comprehensive oncology services and Encompass for FFPE (Formalin-fixed, paraffin-embedded) Tissues Services portfolios for our clients," Carol Berry, GM of Asuragen's Pharmaceutical Services Division, said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.